Public Release Summary on the evaluation of inpyrfluxam in the product Excalia Fungicide

This consultation closed on 16 May 2023

Consultation period

18 April 2023 to 16 May 2023

The APVMA is considering an application for registration of the product Excalia Fungicide containing 400 g/L of the new active constituent inpyrfluxam, as a suspension concentrate (SC) formulation. The product is intended for the control of soil-borne Rhizoctonia solani in potatoes and yellow sigatoka in bananas.

We invite comments from 18 April 2023 to 16 May 2023 on whether approval of the active constituent and registration of the product should be granted. The APVMA is able to consider comments relating to the legislative grounds, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety.

Download the Public Release Summary on the evaluation of Excalia Fungicide.

For more information see page 28, APVMA Gazette No. 8, 18 April 2023.

Please note: submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).

Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:



Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Submissions received

The APVMA sought comments from interested stakeholders on inpyrfluxam in the product Excalia Fungicide, in a consultation that closed on 16 May 2023. No submissions were received.

Consultation feedback

We have completed our assessment and finalised registration of the product.

Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.